The objective of the present study was to determine the frequency of Staphylococcus aureus nasal carriage among dialysis and kidney transplant patients, to identify the antimicrobial resistance profile of these strains and to verify their genetic profiles with the RW3A primer. The study included 159 individuals, comprising 111 dialysis and 48 kidney transplant patients. Of the 48 transplant patients, 75% were positive for S.
INTRODUCTION
Nasal colonization by Staphylococcus spp. begins soon after birth, increases during infancy and decreases in adulthood 
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Phenotypic and genotypic characteristics of S. aureus aureus in the nasopharynx, 30% are intermittent carriers, and 50% are non-carriers (15, 45) .
Staphylococcus aureus and coagulase-negative
Staphylococcus spp. are among the most prevalent pathogens of dialysis and kidney transplant patients (1, 17) . These individuals possess risk factors for colonization and infection with multidrug-resistant S. aureus because of their frequent and prolonged use of antimicrobials. Moreover, these patients undergo frequent admission to the hospital and invasive procedures and maintain contact with colonized patients and professionals. Kidney transplant recipients are at additional risk due to the use of immunosuppressive therapies, which are initiated soon after transplant (19, 36) .
S. aureus is highly versatile in acquiring antimicrobial
resistance, especially to beta-lactam drugs such as oxacillin (4, 26 (10) and to trace and identify the transmission source. The RW3A primer is a repetitive sequence that permits the genetic distinction of phenotypically equivalent strains of S. aureus (35) .
Considering the importance of nasal carriage of S. aureus in the epidemiology of staphylococcal infection and that a significant percentage of these infections are of endogenous origin (29) , the following objectives were proposed for this study: to investigate the frequency of nasal carriage of S.
aureus among dialysis and kidney transplant patients, to identify the resistance profiles of these isolates for commonly used antimicrobial therapies; to verify the presence of the mecA gene in oxacillin-resistant samples and to identify the genetic profile of the samples and correlate the findings. and one was resistant to oxacillin (ATCC 43300). Halo diameters were compared with those described in Table 1 ,
MATERIALS AND METHODS
Study site and population
document M100-S20 of the Clinical and Laboratory Standards
Institute (6) . Results that were interpreted as intermediate were considered to be resistant. The presence of the mecA gene was identified in eight of the ten samples (80%) that were resistant to oxacillin by MIC.
Determination of Minimum Inhibitory
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